B P International

Diabetes Type I and Type II have an increased risk of early atherosclerotic CVD, such as CHD and PAD [1], and it is well known that glucose control improves TG levels and cholesterol-lowering has beneficial effects on CVD outcomes in T1DM and T2DM. Author (S) Details Rajesh Jain Diabetes Prevention Control Project, National Health Mission, India. Susanne Olejas World Diabetes Foundation, Denmark. Sanjeev Davey Muzaffarnagar Medical College, India. Rachna Jain Department of Obstetrics & Gynecology, Jain Hospital, India. Reza Shoghli Department of Cardiology, Azad University of Tehran, Iran. Mohammad Iqbal Consultant Diabetes in Dubai and UK. Seyed Hoseyn Ahmadi Tafti Tehran Heart Centre, Tehran, Iran. Siyamak Jalal hosseini Tehran Heart Centre, Tehran, Iran. View Book :- https://stm.bookpi.org/NFMMR-V14/article/view/3388

Aims: To issue a consensus statement on Lipids and Cardiovascular Health and the impact of their interrelationship in Nigerian Population. Study Design: Experts from a range of relevant disciplines, deliberated on different aspects of Lipids and Cardiovascular Health in the Nigerian Population at a Summit. Place and Duration of Study: The Summit was held in April 2016 at the Nigerian Institute of Medical Research. Methodology: Presentations were made on central themes after which expert participants split into four different groups to consider the questions relevant to different sub themes of the title. Consensus was arrived at, from presentations of groups at plenary. Conclusion: With the increase in the prevalence of NCDs, especially Cardiovascular Disease in Nigeria, and the documented evidence of deleterious effects of lipids, the expert panel called for an urgent need to advocate for the general public and health professionals to make heart-friendly...

Introduction: Diabetic dyslipidemia (DD)  is  a collection  of  quantitative,  qualitative and  kinetic  lipid abnormalities associated with diabetes mellitus that together caused the lipid profile to become more atherogenic.  It  consists  of  elevated  serum  concentration  of  triglyceride-cholesterol  (TG-C),  a  high serum level of small dense low density lipoprotein-cholesterol (sd LDL-C), low level of high-density lipoprotein-cholesterol (HDL-C) and normal to slightly elevated level of total low density lipoprotein-cholesterol (LDL-C). Aims: Diabetic  dyslipidemia  is  a  recognized  risk  factor  for  coronary  heart  disease  (CHD). Plant medicinal  agents  such  as Cymbopogon  citratus (C.  citratus)  have  shown  potential  as alternative therapies for reducing cardiovascular ...